DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
46 hedge funds and large institutions have $7.38M invested in DMK Pharmaceuticals Corporation Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
46
Holding in Top 10
–
Calls
$673K
Puts
$24K
Top Buyers
| 1 | +$64.2K | |
| 2 | +$40K | |
| 3 | +$36.3K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$31.4K |
| 5 |
BlackRock
New York
|
+$15.5K |
Top Sellers
| 1 | -$210K | |
| 2 | -$173K | |
| 3 | -$136K | |
| 4 |
Millennium Management
New York
|
-$84K |
| 5 |
JPMorgan Chase & Co
New York
|
-$75.7K |